Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
MS436 REF: TM-T1854CAS: 1395084-25-9 | 97.95% - 98.92% | 43.00 €~1,068.00 € | Mon 16 Dec 24 | |
4-[(1E)-2-(2-Amino-4-hydroxy-5-methylphenyl)diazenyl]-N-2-pyridinylbenzenesulfonamide REF: TR-A612095CAS: 1395084-25-9 | - - - | 1,045.00 € | Fri 17 Jan 25 | |
MS436 REF: 3D-VFC08425CAS: 1395084-25-9 | Min. 95% | To inquire | Tue 21 Jan 25 | |
MS-436 REF: 10-F390265CAS: 1395084-25-9 | >98% | - - - | Discontinued product |
MS436
CAS:1395084-25-9
MS436 is a selective, small-molecule inhibitor for the BRD4 bromodomains.
Formula:
C18H17N5O3S
Purity:
97.95% - 98.92%
Color and Shape:
Solid
Molecular weight:
383.42
Ref: TM-T1854
2mg | 43.00 € | ||
5mg | 64.00 € | ||
10mg | 102.00 € | ||
25mg | 191.00 € | ||
50mg | 341.00 € | ||
100mg | 498.00 € | ||
500mg | 1,068.00 € | ||
1mL*10mM (DMSO) | 72.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
4-[(1E)-2-(2-Amino-4-hydroxy-5-methylphenyl)diazenyl]-N-2-pyridinylbenzenesulfonamide
Controlled ProductCAS:1395084-25-9
Formula:
C18H17N5O3S
Color and Shape:
Neat
Molecular weight:
829.513
Ref: TR-A612095
50mg | 1,045.00 € |
Estimated delivery in United States, on Friday 17 Jan 2025
MS436
CAS:1395084-25-9
MS436 is a chemical compound that is currently in clinical trials for the treatment of …
Formula:
C18H17N5O3S
Purity:
Min. 95%
Molecular weight:
383.42 g/mol
Ref: 3D-VFC08425
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Ref: 10-F390265
5mg | Discontinued | Request information | |
25mg | Discontinued | Request information |